NSCLC, RECURRENT
Clinical trials for NSCLC, RECURRENT explained in plain language.
Never miss a new study
Get alerted when new NSCLC, RECURRENT trials appear
Sign up with your email to follow new studies for NSCLC, RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo aims to overcome resistance in Late-Stage lung cancer
Disease control Recruiting nowThis study tests whether adding pirfenidone to the immunotherapy drug atezolizumab can improve tumor shrinkage and reduce treatment resistance in people with stage 4 or recurrent non-small cell lung cancer. About 25 adults who have already tried at least one prior treatment will …
Matched conditions: NSCLC, RECURRENT
Phase: PHASE1, PHASE2 • Sponsor: University of Kansas Medical Center • Aim: Disease control
Last updated May 17, 2026 06:43 UTC
-
Engineered immune cells take aim at Hard-to-Treat cancers
Disease control Recruiting nowThis study tests a new type of CAR T cell therapy for adults with advanced solid tumors (like colorectal, lung, or pancreatic cancer) that have lost a specific marker on their cells. The treatment uses the patient's own immune cells, modified to target cancer cells while protecti…
Matched conditions: NSCLC, RECURRENT
Phase: PHASE1, PHASE2 • Sponsor: A2 Biotherapeutics Inc. • Aim: Disease control
Last updated May 15, 2026 11:55 UTC